Thermo Fisher Scientific Inc (NYSE:TMO) Shorted Shares Decreased By 9.24%

October 13, 2018 - By Linda Rogers

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Investors sentiment increased to 1.08 in 2018 Q2. Its up 0.22, from 0.86 in 2018Q1. It improved, as 43 investors sold Thermo Fisher Scientific Inc. shares while 378 reduced holdings. 100 funds opened positions while 356 raised stakes. 332.19 million shares or 0.06% more from 331.98 million shares in 2018Q1 were reported.
Mairs And Power has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2,060 shares. Jane Street Group Lc reported 0.01% stake. Northeast Investment Management holds 2.16% or 123,392 shares. Manchester Management Ltd Com stated it has 0.2% in Thermo Fisher Scientific Inc. (NYSE:TMO). Natl Invest Wi invested in 13,758 shares. Clearbridge Ltd Co has 314 shares for 0% of their portfolio. Stratos Wealth Prns Ltd accumulated 0.2% or 21,148 shares. Wellington Management Gru Llp holds 0.47% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 10.10M shares. Pnc holds 0.14% or 679,808 shares in its portfolio. Heritage Wealth Advsrs invested 0.09% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Wesbanco National Bank & Trust Incorporated owns 47,821 shares for 0.51% of their portfolio. Stonebridge Cap Advsr Limited Company owns 35,760 shares or 1.61% of their US portfolio. Bartlett & Limited Liability Corp has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Tudor Et Al has invested 0.04% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Us Commercial Bank De holds 0.15% or 232,922 shares in its portfolio.

Since May 18, 2018, it had 0 insider buys, and 4 sales for $21.13 million activity. On Wednesday, June 13 CASPER MARC N sold $10.89 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 50,000 shares. HARRIS C MARTIN had sold 206 shares worth $44,174 on Friday, May 18.

The stock of Thermo Fisher Scientific Inc (NYSE:TMO) registered a decrease of 9.24% in short interest. TMO’s total short interest was 3.68M shares in October as published by FINRA. Its down 9.24% from 4.05 million shares, reported previously. With 928,200 shares average volume, it will take short sellers 4 days to cover their TMO’s short positions.

The stock increased 2.35% or $5.32 during the last trading session, reaching $231.41. About 1.66 million shares traded or 22.82% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.20% since October 13, 2017 and is uptrending. It has outperformed by 7.58% the S&P500.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $93.21 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 39.08 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 4 analysts covering Thermo Fisher Scientific (NYSE:TMO), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Thermo Fisher Scientific had 7 analyst reports since April 26, 2018 according to SRatingsIntel. Morgan Stanley maintained the stock with “Overweight” rating in Friday, July 13 report. The stock has “Overweight” rating by Morgan Stanley on Wednesday, October 10. The firm has “Overweight” rating given on Monday, September 24 by Barclays Capital. The firm earned “Overweight” rating on Thursday, April 26 by Morgan Stanley. The company was maintained on Thursday, July 26 by Morgan Stanley. The company was downgraded on Monday, September 17 by Goldman Sachs. Citigroup maintained the shares of TMO in report on Wednesday, October 10 with “Buy” rating.

More recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Bizjournals.com which released: “Mass. firms lost $36B in value in Wednesday’s stock selloff” on October 11, 2018. Also Seekingalpha.com published the news titled: “Premarket analyst action – healthcare” on September 17, 2018. Seekingalpha.com‘s news article titled: “Thermo Fisher in-licenses CRISPR technologies” with publication date: September 18, 2018 was also an interesting one.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>